tradingkey.logo

Standard BioTools Inc

LAB
查看详细走势图
1.380USD
-0.090-6.12%
收盘 12/26, 16:00美东报价延迟15分钟
529.39M总市值
亏损市盈率 TTM

Standard BioTools Inc

1.380
-0.090-6.12%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-6.12%

5天

-15.34%

1月

-3.50%

6月

+15.97%

今年开始到现在

-21.14%

1年

-24.18%

查看详细走势图

TradingKey Standard BioTools Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

Standard BioTools Inc当前公司基本面数据相对非常健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名99/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价1.55。中期看,股价处于平稳状态。近一个月,市场表现较差,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Standard BioTools Inc评分

相关信息

行业排名
99 / 207
全市场排名
249 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 3 位分析师
买入
评级
1.550
目标均价
+6.16%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Standard BioTools Inc亮点

亮点风险
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
业绩高增长
公司营业收入稳步增长,连续3年增长78.09%
估值低估
公司最新PE估值-4.12,处于3年历史低位
机构减仓
最新机构持股277.96M股,环比减少8.99%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值29.11K
活跃度降低
近期活跃度降低,过去20天平均换手率-0.65

Standard BioTools Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Standard BioTools Inc简介

Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
公司代码LAB
公司Standard BioTools Inc
CEOEgholm (Michael)
网址https://www.standardbio.com/

常见问题

Standard BioTools Inc(LAB)的当前股价是多少?

Standard BioTools Inc(LAB)的当前股价是 1.380。

Standard BioTools Inc的股票代码是什么?

Standard BioTools Inc的股票代码是LAB。

Standard BioTools Inc股票的52周最高点是多少?

Standard BioTools Inc股票的52周最高点是2.140。

Standard BioTools Inc股票的52周最低点是多少?

Standard BioTools Inc股票的52周最低点是0.920。

Standard BioTools Inc的市值是多少?

Standard BioTools Inc的市值是529.39M。

Standard BioTools Inc的净利润是多少?

Standard BioTools Inc的净利润为-184.90M。

现在Standard BioTools Inc(LAB)的股票是买入、持有还是卖出?

根据分析师评级,Standard BioTools Inc(LAB)的总体评级为买入,目标价格为1.550。

Standard BioTools Inc(LAB)股票的每股收益(EPS TTM)是多少

Standard BioTools Inc(LAB)股票的每股收益(EPS TTM)是-0.335。
KeyAI